The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for certain activity generated through this link. Prices displayed are informational.

CVS Health Corporation (NYSE:CVS) was among the stocks Jim Cramer commented on as he advised investors on how to take advantage of Wednesday's market rotation. Cramer showed a positive sentiment toward the stock, as he said:

How about these outsized moves in the health insurers and the drug distributors? Oh, I like these. I bet the gains in CVS will be long-lasting. I like UnitedHealth very much here. Humana is doing great.

Stock market data. Photo by Photo by Alesia Kozik

CVS Health Corporation (NYSE:CVS) provides healthcare solutions through insurance, pharmacy benefit management, and retail pharmacy services. Cramer discussed the company's latest quarter during the May 6 episode and commented:

In Friday night's game plan, I told you to expect a great quarter from CVS Health, and that's exactly what we got this very morning. CVS also owns Aetna, a huge health insurance company, and Caremark, the number one pharmacy benefit manager. Today, they reported a magnificent 39 cent earnings beat of $2.18 basis with higher than expected revenue, and management raised their full year forecast pretty substantially. As a result, the stock shot up 7.7% today, reaching a three-year high… The stock went up a lot, but the earnings went up, so it's not more expensive. I would argue that it's cheaper.

While we acknowledge the potential of CVS as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock.

READ NEXT: 33 Stocks That Should Double in 3 Years and 15 Stocks That Will Make You Rich in 10 Years 

Disclosure: None. Follow Insider Monkey on Google News.